Correction to: Real-World Clinical Practice Use of 8-Week Glecaprevir/Pibrentasvir in Treatment-Naïve Patients with Compensated Cirrhosis (Advances in Therapy, (2020), 37, 9, (4033-4042), 10.1007/s12325-020-01449-0)

Pietro Lampertico; Stefan Mauss; Marcello Persico; Stephen T. Barclay; Steven Marx; Kristina Lohmann; Mark Bondin; Zhen Zhen Zhang; Fiona Marra; Pamela S. Belperio; Heiner Wedemeyer; Steven Flamm

doi:10.1007/s12325-020-01482-z

Correction to: Real-World Clinical Practice Use of 8-Week Glecaprevir/Pibrentasvir in Treatment-Naïve Patients with Compensated Cirrhosis (Advances in Therapy, (2020), 37, 9, (4033-4042), 10.1007/s12325-020-01449-0)

Pietro Lampertico^*, Stefan Mauss, Marcello Persico, Stephen T. Barclay, Steven Marx, Kristina Lohmann, Mark Bondin, Zhen Zhen Zhang, Fiona Marra, Pamela S. Belperio, Heiner Wedemeyer, Steven Flamm

^*Corresponding author for this work

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

In the original article, there is an error in Fig. 1. The correct Fig. 1 is given below: (Figure presented.).

Original language	English (US)
Pages (from-to)	4755-4756
Number of pages	2
Journal	Advances in Therapy
Volume	37
Issue number	11
DOIs	https://doi.org/10.1007/s12325-020-01482-z
State	Published - Nov 1 2020

ASJC Scopus subject areas

Pharmacology (medical)

Access to Document

10.1007/s12325-020-01482-z

Fingerprint

Dive into the research topics of 'Correction to: Real-World Clinical Practice Use of 8-Week Glecaprevir/Pibrentasvir in Treatment-Naïve Patients with Compensated Cirrhosis (Advances in Therapy, (2020), 37, 9, (4033-4042), 10.1007/s12325-020-01449-0)'. Together they form a unique fingerprint.

Cite this

Lampertico, P., Mauss, S., Persico, M., Barclay, S. T., Marx, S., Lohmann, K., Bondin, M., Zhang, Z. Z., Marra, F., Belperio, P. S., Wedemeyer, H., & Flamm, S. (2020). Correction to: Real-World Clinical Practice Use of 8-Week Glecaprevir/Pibrentasvir in Treatment-Naïve Patients with Compensated Cirrhosis (Advances in Therapy, (2020), 37, 9, (4033-4042), 10.1007/s12325-020-01449-0). Advances in Therapy, 37(11), 4755-4756. https://doi.org/10.1007/s12325-020-01482-z

@article{d4279d8605a94369b39b7b4797386065,

title = "Correction to: Real-World Clinical Practice Use of 8-Week Glecaprevir/Pibrentasvir in Treatment-Na{\"i}ve Patients with Compensated Cirrhosis (Advances in Therapy, (2020), 37, 9, (4033-4042), 10.1007/s12325-020-01449-0)",

abstract = "In the original article, there is an error in Fig. 1. The correct Fig. 1 is given below: (Figure presented.).",

author = "Pietro Lampertico and Stefan Mauss and Marcello Persico and Barclay, {Stephen T.} and Steven Marx and Kristina Lohmann and Mark Bondin and Zhang, {Zhen Zhen} and Fiona Marra and Belperio, {Pamela S.} and Heiner Wedemeyer and Steven Flamm",

note = "Publisher Copyright: {\textcopyright} 2020, The Author(s).",

year = "2020",

month = nov,

day = "1",

doi = "10.1007/s12325-020-01482-z",

language = "English (US)",

volume = "37",

pages = "4755--4756",

journal = "Advances in Therapy",

issn = "0741-238X",

publisher = "Health Communications Inc.",

number = "11",

}

Lampertico, P, Mauss, S, Persico, M, Barclay, ST, Marx, S, Lohmann, K, Bondin, M, Zhang, ZZ, Marra, F, Belperio, PS, Wedemeyer, H & Flamm, S 2020, 'Correction to: Real-World Clinical Practice Use of 8-Week Glecaprevir/Pibrentasvir in Treatment-Naïve Patients with Compensated Cirrhosis (Advances in Therapy, (2020), 37, 9, (4033-4042), 10.1007/s12325-020-01449-0)', Advances in Therapy, vol. 37, no. 11, pp. 4755-4756. https://doi.org/10.1007/s12325-020-01482-z

Correction to : Real-World Clinical Practice Use of 8-Week Glecaprevir/Pibrentasvir in Treatment-Naïve Patients with Compensated Cirrhosis (Advances in Therapy, (2020), 37, 9, (4033-4042), 10.1007/s12325-020-01449-0). / Lampertico, Pietro; Mauss, Stefan; Persico, Marcello et al.

In: Advances in Therapy, Vol. 37, No. 11, 01.11.2020, p. 4755-4756.

Research output: Contribution to journal › Comment/debate › peer-review

TY - JOUR

T1 - Correction to

T2 - Real-World Clinical Practice Use of 8-Week Glecaprevir/Pibrentasvir in Treatment-Naïve Patients with Compensated Cirrhosis (Advances in Therapy, (2020), 37, 9, (4033-4042), 10.1007/s12325-020-01449-0)

AU - Lampertico, Pietro

AU - Mauss, Stefan

AU - Persico, Marcello

AU - Barclay, Stephen T.

AU - Marx, Steven

AU - Lohmann, Kristina

AU - Bondin, Mark

AU - Zhang, Zhen Zhen

AU - Marra, Fiona

AU - Belperio, Pamela S.

AU - Wedemeyer, Heiner

AU - Flamm, Steven

PY - 2020/11/1

Y1 - 2020/11/1

N2 - In the original article, there is an error in Fig. 1. The correct Fig. 1 is given below: (Figure presented.).

AB - In the original article, there is an error in Fig. 1. The correct Fig. 1 is given below: (Figure presented.).

UR - http://www.scopus.com/inward/record.url?scp=85090828462&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85090828462&partnerID=8YFLogxK

U2 - 10.1007/s12325-020-01482-z

DO - 10.1007/s12325-020-01482-z

M3 - Comment/debate

C2 - 32915409

AN - SCOPUS:85090828462

SN - 0741-238X

VL - 37

SP - 4755

EP - 4756

JO - Advances in Therapy

JF - Advances in Therapy

IS - 11

ER -

Lampertico P, Mauss S, Persico M, Barclay ST, Marx S, Lohmann K et al. Correction to: Real-World Clinical Practice Use of 8-Week Glecaprevir/Pibrentasvir in Treatment-Naïve Patients with Compensated Cirrhosis (Advances in Therapy, (2020), 37, 9, (4033-4042), 10.1007/s12325-020-01449-0). Advances in Therapy. 2020 Nov 1;37(11):4755-4756. doi: 10.1007/s12325-020-01482-z

Correction to: Real-World Clinical Practice Use of 8-Week Glecaprevir/Pibrentasvir in Treatment-Naïve Patients with Compensated Cirrhosis (Advances in Therapy, (2020), 37, 9, (4033-4042), 10.1007/s12325-020-01449-0)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this